drugset / Trial / NCT00641667

An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain

NCT00641667

Phase 3 Completed 66 enrolled Janssen Pharmaceutical K.K.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of fentanyl one-day transdermal patch (patch containing a drug that is put on the skin so the drug will enter the body through the skin) in participants switched from morphine preparations, oral oxycodone preparations, fentanyl citrate injection or fentanyl patch for cancer pain.

Timeline

Start
2008-01
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12.5 ug Topical
Subject Fentanyl Other / unclassified 100 ug Topical

Indications